News
Vietnam Investment Review on MSN2d
Ascletis Unveils ASC47 Weight Loss Drug Candidate
ASC47 is an adipose-targeted, once-monthly subcutaneously (SQ) injected thyroid hormone receptor beta (THRβ) selective small ...
Ascletis Pharma, Inc. ( ($HK:1672) ) just unveiled an update. Ascletis Pharma Inc. announced promising preclinical results for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback